Press Release
April 22, 2021

Goodwin Israel Practice Advises on Over $400 Million in Multiple Financings, a $28 Million Public Offering, and a De-SPAC

As the technology, life sciences, and private equity industries continue to fuel deal activity around the world, Goodwin’s Israel practice continues its momentum as the go-to law firm for Israeli companies, founders, and investors in these sectors. In the past month alone, the practice advised five Israel-based or Israeli-founded technology and life sciences companies in raising over $400 million in funding; represented the lead investors in the financing of two Israeli-founded technology companies in an aggregate amount of $90 million; and counseled the financial advisors on a de-SPAC transaction with an Israel-based target. This activity follows a prolific 2020, during which Goodwin’s Israel practice handled over 20 deals involving Israel-based investors, founders or companies, including mergers and acquisitions, equity financings, and public offerings. Select transactions from the past month include:

Goodwin’s Israel practice provides solutions and produces results for companies doing business in Israel, as well as investors interested in investment opportunities in the region, by leveraging the experience of lawyers working across the firm’s practices areas and global office locations. Learn more about Goodwin’s Israel practice here.